Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Saxena

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|June 3, 2015
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated CirrhosisVarun Saxena, Lisa Nyberg, Marypat Pauly, et al.
Frontiers in Chemistry|June 13, 2020
Chain-End Modifications and Sequence Arrangements of Antimicrobial Peptoids for Mediating Activity and Nano-AssemblyAbshar Hasan, Varun Saxena, Valeria Castelletto, et al.
Gastro Hep Advances|May 29, 2026
Baveno Criteria Spare Endoscopies Among Patients With Compensated Cirrhosis Within a Large US Healthcare SystemMarcia Leung, Mehrnaz Siavoshi, Nathan Billet, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis CVarun Saxena, Jennifer C Lai, Jacqueline G O'Leary, et al.
The Journal of Infection|August 31, 2024
IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis CThomas R O'Brien, David J Witt, Varun Saxena, et al.
JAMA Network Open|July 11, 2024
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver DiseaseLuis A Rodriguez, Julie A Schmittdiel, Liyan Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2016
Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal functionVarun Saxena, Farrukh M Koraishy, Meghan E Sise, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2021
Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting AntiviralsJennifer O Lam, Leo B Hurley, Jennifer B Lai, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|June 3, 2015
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated CirrhosisVarun Saxena, Lisa Nyberg, Marypat Pauly, et al.
Frontiers in Chemistry|June 13, 2020
Chain-End Modifications and Sequence Arrangements of Antimicrobial Peptoids for Mediating Activity and Nano-AssemblyAbshar Hasan, Varun Saxena, Valeria Castelletto, et al.
Gastro Hep Advances|May 29, 2026
Baveno Criteria Spare Endoscopies Among Patients With Compensated Cirrhosis Within a Large US Healthcare SystemMarcia Leung, Mehrnaz Siavoshi, Nathan Billet, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis CVarun Saxena, Jennifer C Lai, Jacqueline G O'Leary, et al.
The Journal of Infection|August 31, 2024
IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis CThomas R O'Brien, David J Witt, Varun Saxena, et al.
JAMA Network Open|July 11, 2024
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver DiseaseLuis A Rodriguez, Julie A Schmittdiel, Liyan Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2016
Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal functionVarun Saxena, Farrukh M Koraishy, Meghan E Sise, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2021
Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting AntiviralsJennifer O Lam, Leo B Hurley, Jennifer B Lai, et al.
Pageof 5